Vivos Therapeutics (VVOS) News Today → Urgent Nvidia Warning (From Altimetry) (Ad) Free VVOS Stock Alerts $2.63 0.00 (0.00%) (As of 05/3/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineVivos Therapeutics expects increased adoption of oral medical devices following Medicare reimbursement approvalproactiveinvestors.com - April 11 at 3:32 PMVivos Therapeutics receives approval for Medicare reimbursement for flagship Oral Medical Devicesfinance.yahoo.com - April 9 at 6:42 PMVivos Gets Approval To Facilitate Full Medicare Reimbursement For CARE Sleep Apnea Oral Devicesmarkets.businessinsider.com - April 9 at 1:41 PMWhat's Going On With Vivos Therapeutics Stock?msn.com - April 9 at 1:41 PMMedicare to reimburse for Vivos CARE sleep apnea devicesmsn.com - April 9 at 1:41 PMVivos Therapeutics CARE oral medical devices approved for Medicare reimbursementproactiveinvestors.com - April 9 at 9:31 AMWhy Is Vivos Therapeutics (VVOS) Stock Up 16% Today?investorplace.com - April 9 at 8:53 AMVivos Therapeutics files to sell 1.73M shares of common stock for holdersmsn.com - April 9 at 8:41 AMVivos Therapeutics’ Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursementfinance.yahoo.com - April 9 at 8:41 AMVivos Therapeutics' Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursementglobenewswire.com - April 9 at 7:30 AMVivos Therapeutics highlights path to cash flow positivity after FDA clearanceproactiveinvestors.com - April 1 at 9:07 AMVivos Therapeutics Full Year 2023 Earnings: Misses Expectationsfinance.yahoo.com - March 31 at 1:42 PMVivos Therapeutics, Inc. (VVOS) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 30 at 12:38 PMVivos Therapeutics Shares Fall After Wider-Than-Expected 4Q Lossmarketwatch.com - March 29 at 1:13 AMVivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Updateglobenewswire.com - March 28 at 4:05 PMVivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Callglobenewswire.com - March 28 at 7:30 AMVivos Therapeutics Stock (NASDAQ:VVOS), Short Interest Reportbenzinga.com - February 22 at 12:09 PMVivos Therapeutics Stock (NASDAQ:VVOS) Insider Tradesbenzinga.com - February 22 at 7:09 AMVivos Therapeutics secures $4 million through warrant exerciseinvesting.com - February 18 at 12:39 AMVivos Therapeutics Announces Exercise of Warrants for Approximately $4.0 Million Aggregate Gross Proceedsfinance.yahoo.com - February 15 at 9:27 AMVivos Therapeutics sees gross proceeds of $4M from exercise of warrantproactiveinvestors.com - February 15 at 9:13 AMVivos Therapeutics CEO Kirk Huntsman Discusses FDA Approval and Market Disruptionsfinance.yahoo.com - February 12 at 9:45 AMVivos Therapeutics, Inc: Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth Opportunitiesfinanznachrichten.de - February 6 at 10:18 AMVivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth Opportunitiesfinance.yahoo.com - February 6 at 10:18 AMVivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company’s Proprietary Oral Medical Devices to Treat Severe OSAfinance.yahoo.com - January 8 at 9:45 AMmarketbeat.com - December 18 at 2:37 PMVivos Therapeutics announces women-led airway health eventproactiveinvestors.com - December 11 at 12:22 PMVivos Therapeutics Presents Groundbreaking Event: “Empowering Women to Champion Airway”finance.yahoo.com - December 11 at 12:22 PMBlack Swan: this small cap surged over 1000% last weekmarketbeat.com - December 4 at 6:03 AMVivos Therapeutics severe sleep apnea treatment’s a ‘breakthrough’, says CEOproactiveinvestors.com - December 1 at 8:28 PMThinking about buying stock in Minim Inc, Walmart, Farfetch Ltd, Qualcomm, or Vivos Therapeutics Inc?benzinga.com - November 30 at 1:04 PMWhy Is Vivos Therapeutics (VVOS) Stock Down 35% Today?investorplace.com - November 30 at 10:05 AMPhilips shares slump as FDA says sleep product may overheatmsn.com - November 30 at 12:47 AMVivos Therapeutics: Who is the medical device company creating frenzy in the markets?proactiveinvestors.com - November 29 at 7:47 PMmarketbeat.com - November 29 at 3:56 PMmarketbeat.com - November 29 at 3:32 PMmarketbeat.com - November 29 at 3:19 PMmarketbeat.com - November 29 at 3:15 PMmarketbeat.com - November 29 at 3:01 PMmarketbeat.com - November 29 at 2:51 PMVivos Therapeutics receives first ever FDA 510(k) clearance...Vivos Therapeutics receives first ever FDA 510(k) clearance for...proactiveinvestors.com - November 29 at 2:43 PMVivos Therapeutics’ stock soars as sleep apnea device gets regulatory clearancemsn.com - November 29 at 2:43 PMUPDATE 2-US FDA clears Vivos Therapeutics' oral device for sleep apneafinance.yahoo.com - November 29 at 2:43 PMVivos Therapeutics hits major milestone with FDA clearance for treating severe sleep apneafinance.yahoo.com - November 29 at 2:43 PMmarketbeat.com - November 29 at 2:35 PMWhy Is Vivos Therapeutics (VVOS) Stock Up 290% Today?investorplace.com - November 29 at 1:01 PMmarketbeat.com - November 29 at 10:55 AMmarketbeat.com - November 29 at 10:51 AMmarketbeat.com - November 29 at 10:42 AMmarketbeat.com - November 29 at 9:59 AM Get Vivos Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VVOS and its competitors with MarketBeat's FREE daily newsletter. Email Address Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached. Secure Your Spot Now VVOS Media Mentions By Week VVOS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VVOS News Sentiment▼0.000.43▲Average Medical News Sentiment VVOS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VVOS Articles This Week▼02▲VVOS Articles Average Week Get Vivos Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VVOS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Plus Therapeutics News Today Intelligent Bio Solutions News Today Vapotherm News Today NeuroMetrix News Today Avinger News Today Titan Medical News Today Acutus Medical News Today Sharps Technology News Today Venus Concept News Today Aethlon Medical News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VVOS) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchAutomatic Income (from home)Awesomely, LLCClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsCould Your Accounts Be Frozen?Allegiance GoldFW: 234x GainWeiss RatingsStock-Picking AI Predicts #1 Stock of 2024Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vivos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
